BHCBausch Health Companies Inc.
$6.04-10% 1Y
$6.04
$4.4452 weeks$7.90
BHC in its own filings
BHC's filing record carries 2 kinds of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.
793
Events found in the filings · across 2,417 filings · the record starts in 1996
- Hard flags
- 2
Hard flags
- Most recent filing
- Jul 30, 2026
Most recent filing · Form 10-Q
- Record starts
- May 22, 1996
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Oct 28, 2026
- Restatement admitted (non-reliance)historical
- 2016-03-21
- Change in certifying accountant4 occurrences
- 2012-04-10
- Late periodic report2 occurrences
- 2016-05-10
- SEC comment-letter activity59 occurrences
- 2019-09-16
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Jul 29, 2026(877) 281-6642 (toll free)Earnings release · press release
- Jul 1, 2026On June 26, 2026, Mr. Michael Goettler notified Bausch Health Companies Inc. (the “Company”) of his decision to resign from the Board of Directors (the “Board”), effective June 30, 2026, in connection with his appointment as President and Chief Executive Officer of Knoa Pharma LLC. Mr. Goettler’s resignation was not …Director or officer change · Form 8-K
- Apr 29, 2026(877) 281-6642 (toll free)Earnings release · press release
- Mar 2, 2026On February 26, 2026, Bausch Health Companies Inc, (the “Company”) took actions to provide for certain earned 2023 performance share unit awards (“2023 PSUs”) to be paid in cash rather than stock upon vesting, including for named executive officers Thomas Appio and Seana Carson.Director or officer change · Form 8-K
- Jan 2, 2026Bausch + Lomb Credit Agreement Refinancing On January 2, 2026, Bausch + Lomb Corporation (“Bausch + Lomb”), a subsidiary of Bausch Health Companies Inc., entered into an amendment (the “Fourth Amendment”) to the Credit and Guaranty Agreement, dated as of May 10, 2022 (as amended by the First Incremental Amendment …Material agreement entered · Form 8-K
- Dec 29, 2025Exchange Offers On December 26, 2025 (the “Settlement Date”), Bausch Health Companies Inc. (the “Company”) and its indirect wholly owned subsidiary 1261229 B.C. Ltd. (the “Issuer”) completed the previously announced offers to exchange the Company’s outstanding 4.875% Senior Secured Notes due 2028 and 11.00% Senior …Material agreement entered · Form 8-K
- Dec 23, 2025On December 23, 2025, Bausch Health Companies Inc. (the “Company”) announced the final results and expiration, as of 5:00 p.m., New York City time, on December 23, 2025, of its previously announced offers to exchange the Company’s outstanding 4.875% Senior Secured Notes due 2028 and 11.00% Senior Secured Notes due …Other event · Form 8-K
- Dec 12, 2025Bausch + Lomb Credit Agreement Refinancing On December 12, 2025, Bausch + Lomb Corporation (“Bausch + Lomb”), a subsidiary of Bausch Health Companies Inc. (the “Company”), issued a press release announcing that it allocated a $2,802,125,000 tranche (the “Replacement Term Loans”) of new term B loans, the proceeds of …Other event · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
Drug Manufacturers, Specialty & Generic
Ranks #13 of 41 by RyuScore